PAV-220830FLY-328

samples-publishAS-BCG_PAV.xlsx

PAV-220830FLY-328

21419-190910

NHP-220830FLY-61

infusion premed., pre-dosing vitals; HR 170, RR 40, T 102.6. Interim vitals; HR 190, RR 40, T 101.9. End of infusion vitals; HR 210, RR 40, T 101.9. No adverse reaction, infusion premed.

https://fairdomhub.org/sops/795

Blood; Treatment

Fluorescence Activated Cell Sorting; Complete Blood Count Blood Test

Flynn Lab

2019-09-10 00:00:00

JoAnne Flynn

Acetaminophen

Medication

Orally

80

milligram

Anti CD4

Antibody

Intravenously

270

milligram

Diphenhydramine

Medication

Orally

12.5

milligram

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

Not specified

AB-220907FLY-2

Not specified

Not specified

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 8

Created: 3rd Feb 2025 at 21:09

Last updated: 4th Feb 2025 at 00:34

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.16.1)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH